sibutramine has been researched along with Serotonin Syndrome in 5 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
Serotonin Syndrome: An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report a case of serotonin syndrome after an overdose of a non-prescription product containing sibutramine." | 7.78 | Serotonin syndrome following overdose of a non-prescription slimming product containing sibutramine: a case report. ( Lam, PK; Lee, HH; Leung, KS; Mak, TW; Tang, MH; Wong, TW, 2012) |
| "To report a case of serotonin syndrome (SS) after sibutramine overdose in a child." | 7.75 | Serotonin syndrome following sibutramine poisoning in a child, with sequential quantification of sibutramine and its primary and secondary amine metabolites in plasma. ( Barros, RF; Bucaretchi, F; da Costa, JL; de Capitani, EM; Fernandes, LC; Hyslop, S; Lanaro, R; Mello, SM, 2009) |
| " We report a case of serotonin syndrome after an overdose of a non-prescription product containing sibutramine." | 3.78 | Serotonin syndrome following overdose of a non-prescription slimming product containing sibutramine: a case report. ( Lam, PK; Lee, HH; Leung, KS; Mak, TW; Tang, MH; Wong, TW, 2012) |
| "To report a case of serotonin syndrome (SS) after sibutramine overdose in a child." | 3.75 | Serotonin syndrome following sibutramine poisoning in a child, with sequential quantification of sibutramine and its primary and secondary amine metabolites in plasma. ( Barros, RF; Bucaretchi, F; da Costa, JL; de Capitani, EM; Fernandes, LC; Hyslop, S; Lanaro, R; Mello, SM, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bucaretchi, F | 1 |
| de Capitani, EM | 1 |
| Mello, SM | 1 |
| Lanaro, R | 1 |
| Barros, RF | 1 |
| Fernandes, LC | 1 |
| da Costa, JL | 1 |
| Hyslop, S | 1 |
| Lam, PK | 1 |
| Leung, KS | 1 |
| Wong, TW | 1 |
| Lee, HH | 1 |
| Tang, MH | 1 |
| Mak, TW | 1 |
| Warmington, A | 1 |
| Giese, SY | 1 |
| Neborsky, R | 1 |
| Trakas, K | 1 |
| Shear, NH | 1 |
5 other studies available for sibutramine and Serotonin Syndrome
| Article | Year |
|---|---|
Serotonin syndrome following sibutramine poisoning in a child, with sequential quantification of sibutramine and its primary and secondary amine metabolites in plasma.
Topics: Antidotes; Appetite Depressants; Child, Preschool; Chloral Hydrate; Chromatography, High Pressure Li | 2009 |
Serotonin syndrome following overdose of a non-prescription slimming product containing sibutramine: a case report.
Topics: Adult; Anti-Obesity Agents; Cyclobutanes; Drug Overdose; Female; Humans; Nonprescription Drugs; Sero | 2012 |
Serotonin syndrome and the anaesthetist.
Topics: Anesthesia, Inhalation; Cyclobutanes; Drug Administration Schedule; Drug Interactions; Female; Follo | 2005 |
Serotonin syndrome: potential consequences of Meridia combined with Demerol or fentanyl.
Topics: Analgesics, Opioid; Antidepressive Agents; Appetite Depressants; Cyclobutanes; Drug Interactions; Fe | 2001 |
Serotonin syndrome risk with antiobesity drug.
Topics: Adult; Appetite Depressants; Canada; Cyclobutanes; Drug Interactions; Female; Humans; Middle Aged; O | 2000 |